Liberty Research Center

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• IgA nephropathy2 trials
• Chronic kidney disease1 trial
• High blood pressure1 trial
• Lupus (SLE)1 trial

Phase

• Phase 1/21 trial
• Phase 21 trial
• Phase 31 trial
• Phase 41 trial

Status

• Completed2 trials
• Active, not recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Novartis Pharmaceuticals2 trials
• Aurinia Pharmaceuticals Inc.1 trial
• Mineralys Therapeutics Inc.1 trial

Running trials

• Recruiting

  PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis

  NCT07611214· Phase 4· Aurinia Pharmaceuticals Inc.· Source

• Active, not recruiting

  Atrasentan in Patients With IgA Nephropathy

  NCT04573478· Phase 3· Novartis Pharmaceuticals· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lupus (SLE)1 recruiting

Closed trials

• Completed

  Efficacy and Safety of Lorundrostat in Addition to Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) in Subjects With Hypertension and Chronic Kidney Disease (CKD) With Albuminuria

  NCT06150924· Phase 2· Mineralys Therapeutics Inc.· Source

• Completed

  Safety and Tolerability of BION-1301 in Healthy Volunteers and Adults With IgA Nephropathy (IgAN)

  NCT03945318· Phase 1/2· Novartis Pharmaceuticals· Source